Sharescart Research Club logo

Bayer CropScience Overview

Bayer CropScience Ltd is engaged inside the production of insecticides, rodenticides, fungicides and herbicides. The Company operates thru Agri Care section. The Company gives crop solutions for various crops, such as millet, mustard, pulses, cotton, fruits, rice, soybeans, sugar cane, vegetables and wheat. The Company offers diverse pest control solutions, along with Professional Pest Management for household / structural pests and Vector Management for pests that pose a danger to public health. The Company offers numerous manufacturers, inclu...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Bayer CropScience Key Financials

Market Cap ₹20502 Cr.

Stock P/E 36.1

P/B 6.6

Current Price ₹4561.8

Book Value ₹ 695

Face Value 10

52W High ₹6540

Dividend Yield 2.74%

52W Low ₹ 4220.1

Bayer CropScience Share Price

₹ | |

Volume
Price

Bayer CropScience Quarterly Price

Show Value Show %

Bayer CropScience Peer Comparison

Bayer CropScience Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 1740 1617 955 792 1631 1738 1057 1046 1915 1553
Other Income 21 16 15 29 27 23 33 37 19 14
Total Income 1760 1633 970 821 1659 1761 1090 1084 1933 1567
Total Expenditure 1315 1312 827 695 1317 1554 1037 876 1566 1348
Operating Profit 445 321 143 126 342 208 52 208 367 219
Interest 8 4 3 5 4 3 4 6 5 4
Depreciation 31 12 15 16 22 14 15 34 27 14
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 406 306 124 105 316 190 34 168 335 200
Provision for Tax 78 83 31 9 62 54 -1 25 57 48
Profit After Tax 329 223 93 96 254 136 34 143 279 153
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 329 223 93 96 254 136 34 143 279 153
Adjusted Earnings Per Share 73.2 49.6 20.7 21.4 56.6 30.4 7.6 31.9 62.1 34

Bayer CropScience Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 3723 2769 2803 2710 3167 3609 4261 4734 5140 5106 5473 5571
Other Income 91 82 72 39 53 67 66 60 73 81 121 103
Total Income 3814 2851 2874 2749 3221 3676 4327 4794 5213 5187 5595 5674
Total Expenditure 3211 2335 2391 2301 2687 2884 3452 3929 4225 4152 4785 4827
Operating Profit 603 516 484 448 534 792 876 866 988 1035 809 846
Interest 5 10 7 11 10 14 13 13 22 20 17 19
Depreciation 25 25 29 33 44 65 74 65 80 74 85 90
Exceptional Income / Expenses 0 0 0 0 0 -130 5 59 104 0 0 0
Profit Before Tax 574 482 448 404 480 583 795 847 990 941 707 737
Provision for Tax 191 167 157 104 143 109 301 202 232 201 139 129
Profit After Tax 383 315 291 300 337 475 493 645 758 741 568 609
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 383 315 291 300 337 475 493 645 758 741 568 609
Adjusted Earnings Per Share 104.6 89 82.2 87.5 98.3 105.7 109.8 143.7 168.9 164.9 126.5 135.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 7% 5% 9% 4%
Operating Profit CAGR -22% -2% 0% 3%
PAT CAGR -23% -4% 4% 4%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -6% 1% -4% 3%
ROE Average 20% 25% 24% 20%
ROCE Average 25% 33% 33% 29%

Bayer CropScience Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 2033 1839 2057 1778 2239 2573 2550 2524 2712 2849 2850
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1155 1359 1539 1502 1614 1590 1783 2365 2792 2952 3117
Total Current Liabilities 856 538 829 950 1684 1765 2273 2073 1995 1815 2441
Total Liabilities 4044 3737 4425 4230 5537 5928 6607 6962 7500 7616 8408
Fixed Assets 322 290 311 304 409 438 395 441 437 389 445
Other Non-Current Assets 1175 1409 1594 1562 1852 1850 1965 2531 2949 3104 3274
Total Current Assets 2548 2037 2520 2364 3271 3640 4247 3989 4114 4123 4689
Total Assets 4044 3737 4425 4230 5537 5928 6607 6962 7500 7616 8408

Bayer CropScience Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 486 1130 762 838 417 578 1067 1205 781 861 1157
Cash Flow from Operating Activities 200 207 157 121 433 666 687 216 609 952 262
Cash Flow from Investing Activities 485 16 -8 38 -415 -29 7 64 83 0 86
Cash Flow from Financing Activities -42 -590 -73 -581 -158 -148 -556 -703 -613 -656 -619
Net Cash Inflow / Outflow 644 -367 76 -421 -140 489 138 -424 79 296 -272
Closing Cash & Cash Equivalent 1130 762 838 417 578 1067 1205 781 860 1157 885

Bayer CropScience Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 104.64 89.01 82.2 87.49 98.28 105.68 109.82 143.72 168.86 164.92 126.5
CEPS(Rs) 111.56 95.99 90.37 97.14 111.05 120.22 126.19 158.08 186.57 181.4 145.41
DPS(Rs) 21 17 17 18 18 25 115 150 130 140 125
Book NAV/Share(Rs) 555.44 519.6 580.99 518.45 649.8 572.94 568 562.2 604.03 634.61 634.83
Core EBITDA Margin(%) 13.13 15.02 13.98 14.88 13.7 17.66 16.75 14.78 15.51 15.54 10.95
EBIT Margin(%) 14.81 17.01 15.43 15.1 13.97 14.53 16.7 15.77 17.16 15.66 11.53
Pre Tax Margin(%) 14.69 16.67 15.19 14.69 13.68 14.19 16.44 15.53 16.78 15.34 11.26
PAT Margin (%) 9.81 10.91 9.87 10.92 9.6 11.55 10.2 11.84 12.85 12.07 9.04
Cash Profit Margin (%) 10.46 11.76 10.85 12.12 10.85 13.14 11.72 13.02 14.2 13.27 10.39
ROA(%) 10.21 8.1 7.13 6.93 6.9 8.28 7.87 9.51 10.49 9.8 7.09
ROE(%) 20.29 16.27 14.94 15.65 16.83 19.77 19.25 25.43 28.96 26.63 19.93
ROCE(%) 30.63 25.39 23.35 21.65 24.41 24.8 31.5 33.88 38.67 34.56 25.42
Receivable days 45.87 61.65 59.51 80.68 70.58 62.93 55.61 58.91 61.25 57.56 55.55
Inventory Days 52.1 77.64 88.68 100.11 98.63 94.2 86.4 94.98 102.67 99.69 113.49
Payable days 42.41 60.13 57.04 67.53 107.39 112.12 102.62 118.74 114.74 97.05 95.91
PER(x) 31.78 42.34 46.15 48.04 44.61 32.73 48.31 34.67 23.97 31.79 38.95
Price/Book(x) 5.99 7.25 6.53 8.11 6.75 6.04 9.34 8.86 6.7 8.26 7.76
Dividend Yield(%) 0.63 0.45 0.45 0.43 0.41 0.72 2.17 3.01 3.21 2.67 2.54
EV/Net Sales(x) 2.97 4.54 4.49 5.17 4.56 4.01 5.31 4.56 3.37 4.38 3.88
EV/Core EBITDA(x) 18.3 24.36 26.03 31.23 27.06 18.25 25.83 24.93 17.52 21.62 26.23
Net Sales Growth(%) 14.73 -25.63 1.22 -3.31 16.88 13.96 18.06 11.1 8.56 -0.65 7.19
EBIT Growth(%) 29.74 -14.96 -7.49 -8.73 18.14 21.72 35.22 6.52 17.76 -5.08 -24.62
PAT Growth(%) 32.3 -17.73 -7.65 3.13 12.33 40.76 3.92 30.87 17.5 -2.33 -23.3
EPS Growth(%) 32.3 -14.94 -7.65 6.43 12.33 7.53 3.92 30.87 17.5 -2.33 -23.3
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.98 3.79 3.04 2.49 1.94 2.06 1.87 1.92 2.06 2.27 1.92
Quick Ratio(x) 2.32 2.55 2.11 1.71 1.26 1.52 1.29 1.19 1.16 1.42 0.95
Interest Cover(x) 125.67 49.16 65.91 36.73 47.15 43.25 64.06 66.64 45.4 49.03 42.61
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Bayer CropScience Shareholding Pattern

# Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.43 71.43
FII 3.3 3.54 3.62 3.63 3.3 3.42 3.49 3.64 3.79 3.84
DII 13.23 12.7 12.8 12.47 12.08 11.7 11.55 11.38 11.21 11.46
Public 12.04 12.33 12.15 12.47 13.19 13.44 13.53 13.55 13.57 13.27
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Bayer CropScience News

Bayer CropScience Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%
  • Debtor days have improved from 97.05 to 95.91days.
  • Company is almost debt free.

Cons

  • Stock is trading at 6.6 times its book value.
  • The company has delivered a poor profit growth of 3% over past five years.
whatsapp